tiprankstipranks
Trending News
More News >
Blueprint Medicines (BPMC)
NASDAQ:BPMC

Blueprint Medicines (BPMC) Similar Stocks

Compare
605 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Blueprint Medicines
$128.21
$8.28B
20.51%
4 Buy
15 Hold
0 Sell
Hold
Alkermes
$31.20
$5.14B
14.66
24.06%
8 Buy
6 Hold
0 Sell
Moderate Buy
Sarepta Therapeutics
$37.31
$3.84B
19.61
-70.15%
20 Buy
4 Hold
0 Sell
Strong Buy
Axsome Therapeutics
$106.25
$5.41B
46.53%
16 Buy
0 Hold
0 Sell
Strong Buy
BridgeBio Pharma
$39.65
$7.61B
36.72%
14 Buy
1 Hold
0 Sell
Strong Buy
Revolution Medicines
$40.79
$7.82B
2.80%
10 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
BPMC
Blueprint Medicines
128.21
22.66
21.47%
ALKS
Alkermes
30.78
6.28
25.63%
SRPT
Sarepta Therapeutics
37.31
-85.53
-69.63%
AXSM
Axsome Therapeutics
106.25
32.62
44.30%
BBIO
BridgeBio Pharma
39.65
11.79
42.32%
RVMD
Revolution Medicines
41.11
2.49
6.45%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis